Market Intelligence

Access the latest earnings reports, market analysis, hot topics, and individual stock insights

Report Categories

View All

Recent Articles

View All
Oil Prices Slide Amid Hopes of USIran Peace Deal and Strait of Hormuz Reopening Berkshire Hathaway Acquires 26 Billion Stake in Delta Air Lines Signaling Shift in Airline Sector Bet Subramanian Swamy Calls for Ban on Cement Imports from Pakistan Over Security Concerns SEC Delays Tokenized Stock Trading Proposal Amid Pushback Crypto Exchange Stocks Slide Cambodian Opposition Leader Receives Partial Pardon Implications for Investment Climate PBYI Q1 2026 Earnings NarrowerThanExpected Loss Signals Operational Discipline EME Q1 2026 Earnings EPS Surges 1487 Above Estimates Stock Gains AAP Q1 2026 Earnings EPS Crushes Estimates with 68 Surprise Stock Slides OCSL Q1 2026 Earnings Earnings Beat Despite Slight Stock Dip ST Bancorp Inc STBA Q1 2026 Earnings Earnings Beat Expectations with EPS of 094 BranchOut Food Inc BOF Shares Edge Higher Key Levels to Watch Tectonic Therapeutic TECX Rallies 376 as Biotech Momentum Builds Key Levels to Watch Oragenics Inc OGEN Edges Higher as Biotech Volatility Persists Oragenics Inc OGEN Slips Amid Low Volume Hovers Near Key Support FrontRow Starters at Indy 500 Show RaceDay and Financial Edge Over Rivals Astra Microwave Products Q4 Net Profit Surges 44 to Rs 106 Crore Board Recommends Dividend Sebi Chair Tuhin Kanta Pandey Advocates Bond ETFs and Tokenisation as Corporate Debt Fundraising Nears 9 Lakh Crore Berkshire Hathaway Boosts Portfolio With Major Delta Airlines and Alphabet Investments MKTW Q1 2026 Earnings Staggering EPS Miss and Lack of Revenue Disclosure Raise Concerns CRNX Q1 2026 Earnings EPS Surprise Beats Estimates as PreRevenue Biotech Advances Pipeline SWKHL Q3 2025 Earnings Strong EPS Beat Driven by Portfolio Performance PBHC Q4 2025 Earnings Negative EPS of 111 Amidst a Challenging Quarter THRY Q1 2026 Earnings Massive EPS Beat Lifts Shares as Expense Discipline Shines LIXT Q4 2024 Earnings ClinicalStage Biotech Reports perShare Loss as Development Continues